{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:00:35Z","timestamp":1740175235094,"version":"3.37.3"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Coronavirus-19 disease (COVID-19) continues to spread throughout the world. It is known that among patients with hypertension, diabetes, chronic respiratory disease, or cardiovascular diseases, COVID-19 is associated with greater morbidity and mortality compared with patients without these conditions. This correlation is of great importance in pregnant women affected by COVID-19, since it usually leads to the development of a serious clinical complication. In particular, managing hypertensive disorders in pregnancy can be problematic because antihypertensive medications may interact pharmacologically with drugs used to treat COVID-19. This review focuses on the safety of drug treatment for COVID-19 in pregnant women treated with antihypertensive medication. Several databases were searched to identify relevant literature. A few antihypertensive drugs and antithrombotic treatments are known for having a beneficial effect in the management of hypertension and hypertensive disorders in pregnancy. In this review, we focus on the expected drug\u2013drug interactions with the experimental agents most often used to treat COVID-19. The current indications for the management of hypertension-related disorders in pregnancy maintain their validity, while the risk of pharmacological interaction with the currently tested anti-SARS-CoV-2 medications is relatively low.<\/jats:p>","DOI":"10.1093\/ehjcvp\/pvaa105","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:11:50Z","timestamp":1598958710000},"page":"346-351","source":"Crossref","is-referenced-by-count":3,"title":["Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues"],"prefix":"10.1093","volume":"7","author":[{"given":"Silvia","family":"Fogacci","sequence":"first","affiliation":[{"name":"Hypertension and Cardiovascular Risk Research Group, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-0042","authenticated-orcid":false,"given":"Federica","family":"Fogacci","sequence":"additional","affiliation":[{"name":"Hypertension and Cardiovascular Risk Research Group, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elda","family":"Favari","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma, Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P","family":"Toth","sequence":"additional","affiliation":[{"name":"CGH Medical Center, Sterling, IL, and Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-8781","authenticated-orcid":false,"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[{"name":"Hypertension and Cardiovascular Risk Research Group, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-3884","authenticated-orcid":false,"given":"Arrigo F G","family":"Cicero","sequence":"additional","affiliation":[{"name":"Hypertension and Cardiovascular Risk Research Group, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"2021072618100407900_pvaa105-B1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1017\/ice.2020.84","article-title":"Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth","volume":"41","author":"Khan","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2021072618100407900_pvaa105-B2"},{"key":"2021072618100407900_pvaa105-B3","doi-asserted-by":"crossref","first-page":"103122","DOI":"10.1016\/j.jri.2020.103122","article-title":"Why are pregnant women susceptible to COVID-19? An immunological viewpoint","volume":"139","author":"Liu","year":"2020","journal-title":"J Reprod Immunol"},{"key":"2021072618100407900_pvaa105-B4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(20)30365-2","article-title":"What are the risks of COVID-19 infection in pregnant women?","volume":"395","author":"Qiao","year":"2020","journal-title":"Lancet"},{"key":"2021072618100407900_pvaa105-B5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1515\/jpm-2020-0132","article-title":"COVID-19 and pregnancy\u2014where are we now? A review","volume":"48","author":"Rajewska","year":"2020","journal-title":"J Perinat Med"},{"key":"2021072618100407900_pvaa105-B6","doi-asserted-by":"crossref","DOI":"10.1007\/s40267-020-00725-x","article-title":"Preventive measures and management of COVID-19 in pregnancy","author":"Omer","year":"2020","journal-title":"Drugs Ther Perspect"},{"key":"2021072618100407900_pvaa105-B7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10096-020-03897-6","article-title":"Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening","volume":"39","author":"Zhao","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021072618100407900_pvaa105-B8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.cmi.2020.03.034","article-title":"Association of COVID-19 with pregnancy outcomes in health-care workers and general women","volume":"26","author":"Khan","journal-title":"Clin Microbiol Infect"},{"key":"2021072618100407900_pvaa105-B9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"2021072618100407900_pvaa105-B10","first-page":"46","article-title":"COVID-19 and pregnancy: a review of current knowledge","volume":"28(suppl 1","author":"Maleki Dana","year":"2020","journal-title":"Infez Med"},{"key":"2021072618100407900_pvaa105-B11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/INF.0000000000002700","article-title":"COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2021072618100407900_pvaa105-B12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ajog.2003.11.019","article-title":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome","volume":"191","author":"Wong","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1471-0528.2004.00199.x","article-title":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome","volume":"111","author":"Lam","year":"2004","journal-title":"BJOG"},{"key":"2021072618100407900_pvaa105-B14","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S0140-6736(20)30311-1","article-title":"2019-nCoV epidemic: what about pregnancies?","volume":"395","author":"Favre","year":"2020","journal-title":"Lancet"},{"year":"2020","key":"2021072618100407900_pvaa105-B15"},{"key":"2021072618100407900_pvaa105-B16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.03.016","article-title":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network meta-analysis","author":"Bellos","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B17","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2021072618100407900_pvaa105-B18","first-page":"e1","article-title":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B19","doi-asserted-by":"crossref","first-page":"m1086","DOI":"10.1136\/bmj.m1086","article-title":"Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists","volume":"368","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"2021072618100407900_pvaa105-B20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.rmr.2017.12.003","article-title":"Risques associ\u00e9s \u00e0 la prise d\u2019anti-inflammatoires non st\u00e9ro\u00efdiens au cours de la pneumonie [Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia","volume":"35","author":"Voiriot","year":"2018","journal-title":"Rev Mal Respir"},{"key":"2021072618100407900_pvaa105-B21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/uog.22049","article-title":"Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic","volume":"55","author":"Kwiatkowski","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1780005","article-title":"MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?","volume":"178","author":"Clark","year":"2003","journal-title":"J Endocrinol"},{"key":"2021072618100407900_pvaa105-B23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ehjcvp\/pvz031","article-title":"Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis","volume":"6","author":"Galli","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2021072618100407900_pvaa105-B24"},{"key":"2021072618100407900_pvaa105-B25","first-page":"1545","article-title":"American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the","volume":"45","author":"Bushnell","year":"2014","journal-title":"American Heart Association\/American Stroke Association. Stroke"},{"key":"2021072618100407900_pvaa105-B26","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0601856","article-title":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities","volume":"49","author":"Biot","year":"2006","journal-title":"J Med Chem"},{"issue":"1","key":"2021072618100407900_pvaa105-B27","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"2021072618100407900_pvaa105-B28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"2021072618100407900_pvaa105-B29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/aogs.13836","article-title":"Novel corona virus disease (COVID-19) in pregnancy: what clinical recommendations to follow?","volume":"99","author":"Liang","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2021072618100407900_pvaa105-B30","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"2021072618100407900_pvaa105-B31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus"},{"key":"2021072618100407900_pvaa105-B32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1191\/0961203306lu2281rr","article-title":"Lupus nephritis and renal disease in pregnancy","volume":"15","author":"Germain","year":"2006","journal-title":"Lupus"},{"key":"2021072618100407900_pvaa105-B33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11530710-000000000-00000","article-title":"Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release","volume":"70","author":"Kamp","year":"2010","journal-title":"Drugs"},{"key":"2021072618100407900_pvaa105-B34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00059-003-2468-x","article-title":"Schwangerschaft und Kardiomyopathie [Pregnancy and cardiomyopathies]","volume":"28","author":"Maisch","year":"2003","journal-title":"Herz"},{"key":"2021072618100407900_pvaa105-B35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.14821","article-title":"The versatile heparin in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2021072618100407900_pvaa105-B36","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jth.14858","article-title":"Potential of heparin and nafamostat combination therapy for COVID-19","volume":"18","author":"Asakura","year":"2020","journal-title":"J Thromb Haemost"},{"year":"2020","key":"2021072618100407900_pvaa105-B37"},{"key":"2021072618100407900_pvaa105-B38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2015.07.009","article-title":"Mechanism of hydralazine-induced relaxation in resistance arteries during pregnancy: hydralazine induces vasodilation via a prostacyclin pathway","volume":"78","author":"Maille","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"2021072618100407900_pvaa105-B39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajog.2020.04.005","article-title":"Care of the pregnant woman with coronavirus disease 2019 in labor and delivery: anesthesia, emergency cesarean delivery, differential diagnosis in the acutely ill parturient, care of the newborn, and protection of the healthcare personnel","volume":"223","author":"Ashokka","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B40","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25893","article-title":"Evaluation of antiviral therapies for coronavirus disease 2019 pneumonia in Shanghai,","author":"Shi","year":"2020","journal-title":"China. J Med Virol"},{"key":"2021072618100407900_pvaa105-B41","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"2021072618100407900_pvaa105-B42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/ritonavir: a review of its use in the management of HIV infection","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs"},{"key":"2021072618100407900_pvaa105-B43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAD.0b013e3280117f6f","article-title":"Nifedipine\u2013lopinavir\/ritonavir severe interaction: a case report","volume":"21","author":"Baeza","year":"2007","journal-title":"AIDS"},{"key":"2021072618100407900_pvaa105-B44"},{"key":"2021072618100407900_pvaa105-B45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tjog.2020.01.002","article-title":"Factors effective in the prevention of preeclampsia: a systematic review","volume":"59","author":"Rahnemaei","year":"2020","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension"},{"key":"2021072618100407900_pvaa105-B47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2017.03.007","article-title":"Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin","volume":"112","author":"Lipowsky","year":"2017","journal-title":"Microvasc Res"},{"key":"2021072618100407900_pvaa105-B48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5582\/bst.2020.03058","article-title":"Macrolide treatment for COVID-19: will this be the way forward?","volume":"14","author":"Ohe","year":"2020","journal-title":"Biosci Trends"},{"key":"2021072618100407900_pvaa105-B49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.29271\/jcpsp.2019.02.119","article-title":"Clinical effect of low molecular weight heparin sodium combined with magnesium sulfate in the treatment of patients with severe preeclampsia","volume":"29","author":"Wen","year":"2019","journal-title":"J Coll Physicians Surg Pak"},{"key":"2021072618100407900_pvaa105-B50","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709993","article-title":"Successful treatment of preterm labor in association with acute COVID-19 infection","volume":"37","author":"Browne","year":"2020","journal-title":"Am J Perinatol"},{"key":"2021072618100407900_pvaa105-B51","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.clnu.2019.08.015","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Vitamin D supplementation and incident preeclampsia: a systematic review and meta-analysis of randomized clinical trials","volume":"39","author":"Fogacci","year":"2020","journal-title":"Clin Nutr"},{"key":"2021072618100407900_pvaa105-B52","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","article-title":"Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets","volume":"39","author":"Misra","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2021072618100407900_pvaa105-B53","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1002\/rmv.2032","article-title":"The interplay between vitamin D and viral infections","volume":"29","author":"Teymoori-Rad","year":"2019","journal-title":"Rev Med Virol"},{"key":"2021072618100407900_pvaa105-B54","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.dsx.2020.06.071","article-title":"Vitamin D deficiency in patients with diabetes and COVID-19 infection","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2021072618100407900_pvaa105-B55","article-title":"Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity","author":"Panagiotou","year":"2020","journal-title":"Clin Endocrinol"},{"key":"2021072618100407900_pvaa105-B56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s13224-017-0982-7","article-title":"Analyses of nutrients and body mass index as risk factor for preeclampsia","volume":"67","author":"","year":"2017","journal-title":"J Obstet Gynaecol India"},{"key":"2021072618100407900_pvaa105-B57","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3177\/jnsv.64.454","article-title":"The Association between dietary vitamin C\/E and gestational hypertensive disorder: a case\u2013control study","volume":"64","author":"Wang","year":"2018","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2021072618100407900_pvaa105-B58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13054-020-02851-4","article-title":"A new clinical trial to test high-dose vitamin C in patients with COVID-19","volume":"24","author":"Carr","year":"2020","journal-title":"Crit Care"},{"key":"2021072618100407900_pvaa105-B59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00228-020-02868-2","article-title":"Prescription medicines with potential for fetal harm: dispensing before and during pregnancy in New Zealand, 2005\u20132015","volume":"76","author":"Donald","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"2021072618100407900_pvaa105-B60","doi-asserted-by":"crossref","first-page":"e039519","DOI":"10.1136\/bmjopen-2020-039519","article-title":"Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial","volume":"10","author":"Liu","year":"2020","journal-title":"BMJ Open"},{"key":"2021072618100407900_pvaa105-B61","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s13063-020-04547-0","article-title":"Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Beigmohammadi","year":"2020","journal-title":"Trials"},{"key":"2021072618100407900_pvaa105-B62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ajog.2020.04.013","article-title":"Coronavirus disease 2019 during pregnancy: a systematic review of reported cases","volume":"223","author":"Della Gatta","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B63","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000003584","article-title":"Combination antiretroviral therapy and hypertensive disorders of pregnancy","volume":"134","author":"Saums","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2021072618100407900_pvaa105-B64","doi-asserted-by":"crossref","first-page":"l5119","DOI":"10.1136\/bmj.l5119","article-title":"Guideline Committee. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance","volume":"366","author":"Webster","year":"2019","journal-title":"BMJ"},{"key":"2021072618100407900_pvaa105-B65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin\u2013angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2021072618100407900_pvaa105-B66","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"2021072618100407900_pvaa105-B67","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/ciaa444","article-title":"Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials","volume":"71","author":"LaCourse","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021072618100407900_pvaa105-B68","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/jcm9051417","article-title":"Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence","volume":"9","author":"Sardu","year":"2020","journal-title":"J Clin Med"},{"key":"2021072618100407900_pvaa105-B69","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/cells9071652","article-title":"COVID-19, renin\u2013angiotensin system and endothelial dysfunction","volume":"9","author":"Amraei","year":"2020","journal-title":"Cells"},{"key":"2021072618100407900_pvaa105-B70","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2020.1783243","article-title":"The cytokine storm of COVID-19: a spotlight on prevention and protection","author":"Pearce","year":"2020","journal-title":"Expert Opin Ther Targets"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvaa105\/34142489\/pvaa105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/7\/4\/346\/39317095\/pvaa105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/7\/4\/346\/39317095\/pvaa105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T18:11:22Z","timestamp":1627323082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/7\/4\/346\/5903734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,9,10]]},"published-print":{"date-parts":[[2021,7,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa105","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"type":"print","value":"2055-6837"},{"type":"electronic","value":"2055-6845"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,9,10]]}}}